STRATA Skin Sciences, Inc. (SSKN)
Market Cap | 13.02M |
Revenue (ttm) | 32.55M |
Net Income (ttm) | -11.36M |
Shares Out | 35.06M |
EPS (ttm) | -0.33 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 12,342 |
Open | 0.366 |
Previous Close | 0.370 |
Day's Range | 0.366 - 0.400 |
52-Week Range | 0.260 - 1.080 |
Beta | 1.54 |
Analysts | n/a |
Price Target | n/a |
Earnings Date | May 15, 2024 |
About SSKN
STRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company products include XTRAC and Pharos excimer lasers, and VTRAC lamp systems for the treatment systems that are used for the treatment of psoriasis, vitiligo, and other skin ... [Read more]
Financial Performance
In 2023, SSKN's revenue was $33.36 million, a decrease of -7.75% compared to the previous year's $36.16 million. Losses were -$10.83 million, 95.2% more than in 2022.
Financial StatementsNews
STRATA Skin Sciences Reports First Quarter 2024 Financial Results and Provides a Corporate Update
HORSHAM, Penn., May 15, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marke...
STRATA Skin Sciences Surpasses 100 Domestic Installations of TheraClear®X Devices as of March 31, 2024
HORSHAM, Pa., May 14, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketi...
STRATA Skin Sciences to Participate in the Benchmark Healthcare House Call Virtual 1x1 Investor Conference
HORSHAM, Pa., May 13, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketi...
STRATA Skin Sciences to Report First Quarter 2024 Financial Results on May 15, 2024 and Provide Corporate Update
HORSHAM, Penn., May 08, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marke...
STRATA Skin Sciences Announces XTRAC® Comeback Placements in the First Quarter of 2024
HORSHAM, Pa., April 30, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marke...
STRATA Skin Sciences Announces 1-for-10 Reverse Stock Split
HORSHAM, Penn., April 26, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and mar...
STRATA Skin Sciences to Present at the Planet MicroCap Showcase: Vegas 2024
HORSHAM, Pa., April 23, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marke...
STRATA Skin Sciences Announces Renewal of Exclusive Distribution Agreements in China and Japan
Distributors in China and Japan have each maintained exclusive distribution agreements with the Company for over 10 years and collectively accounted for 46% of the Company's total international revenu...
STRATA Skin Sciences Reports Fourth Quarter and Full-Year 2023 Earnings
Company to host conference call and webcast today, March 27, 2024, at 4:30 PM ET Company to host conference call and webcast today, March 27, 2024, at 4:30 PM ET
STRATA Skin Sciences to Report Fourth Quarter and Full-Year 2023 Financial Results on March 27, 2024
HORSHAM, Pa., March 13, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and market...
STRATA Skin Sciences Announces Initiative to Expand Treatment Coverage
HORSHAM, Pa., March 07, 2024 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and market...
STRATA Skin Sciences Announces Successful Amendment to Credit Agreement with MidCap Financial
–Amends certain financial covenants to enhance liquidity and financial flexibility– –Ensures alignment with the Company's current and future business operations–
STRATA Skin Sciences Announces Expansion of Distribution Agreement with Kosmo Meditech
Agreement further solidifies the strength and growth of the partnership between STRATA Skin Sciences and Kosmo Meditech Agreement further solidifies the strength and growth of the partnership between ...
STRATA Skin Science Announces Strengthening of Leadership Team
Shmuel Gov Promoted to Chief Operating Officer Dr. Amandeep Kaur Hired as Vice President of Marketing and Business Growth HORSHAM, Pa., Dec. 04, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NA...
STRATA Skin Sciences to Participate in the Benchmark 12th Annual Discovery One-on-One Investor Conference
HORSHAM, Pa., Dec. 01, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for t...
STRATA Skin Sciences Reports Third Quarter 2023 Revenue
Company to Host Conference Call and Webcast Today, November 14, 2023, at 4:30 PM ET Company to Host Conference Call and Webcast Today, November 14, 2023, at 4:30 PM ET
STRATA Skin Sciences to Report Third Quarter 2023 Financial Results on November 14, 2023
HORSHAM, Pa., Nov. 02, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for t...
STRATA Skin Sciences, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
HORSHAM, Pa., Oct. 31, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN) (the “Company”), a medical technology company dedicated to developing, commercializing and marketing innovativ...
STRATA Skin Sciences to Host Virtual KOL Event on XTRAC® and TheraClear®X
HORSHAM, Pa., Aug. 24, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for t...
STRATA Skin Sciences Reports Second Quarter 2023 Revenue
Company to Host Conference Call and Webcast Today, August 9, 2023, at 4:30 PM ET Company to Host Conference Call and Webcast Today, August 9, 2023, at 4:30 PM ET
STRATA Skin Sciences to Participate in Upcoming August Conferences
HORSHAM, Pa., Aug. 01, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for t...
STRATA Skin Sciences to Report Second Quarter 2023 Financial Results on August 9, 2023
HORSHAM, Pa., July 28, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for t...
STRATA Skin Sciences Secures additional $12 Million Financing with MidCap Financial
HORSHAM, Pa., July 06, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for t...
STRATA Skin Sciences Appoints Dr. Uri Geiger to Chairman of its Board of Directors
HORSHAM, Pa., June 30, 2023 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing and marketing innovative products for t...
STRATA Skin Sciences Announces First Patients Treated in TheraClear®X Clinical Study for Acne
Study evaluating efficacy and safety of TheraClearX on mitigating mild to moderate acne in healthy teenagers and young adults Study evaluating efficacy and safety of TheraClearX on mitigating mild to ...